Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02382354Phase 4Completed
Phase 4, randomised trial of remifentanil, sponsored by Ajou University School of Medicine. Primary endpoint: Successful insertion of i-gel and LMA. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02382354.